1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ALNYLAM PHARMACEUTICALS INC

Alnylam Pharmaceuticals Inc

XNAS: ALNY

Momentum Trap
Download real time

253.11 11.35 (4.69%)

78.27% Gain from 52W Low

582.4K XNAS Volume

XNAS 17 Mar, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Share
17S
8W
4O
0T
32,766.9

Market Cap

High in industry
-117.8

PE TTM

Negative PE TTM
-3.2

PEG TTM

PEG TTM is negative
488.4

Price to Book

High in industry
0.2

Beta 1Year

Very Low volatility
Board Meeting
The board meeting for Alnylam Pharmaceuticals Inc is scheduled for today, for the purpose of Stifel 2025 Virtual CNS Forum See details

Alnylam Pharmaceuticals Inc - ALNY - stock price prediction, stock price target, analyst ratings from 32 analysts

Alnylam Pharmaceuticals Inc has a share price target of US$ 305, revenue growth forecast of 27.6%, and profit growth estimate of 15.4% for FY25, based on top 32 analyst calls.

Forecaster Screeners